中晟全肽

Biotech/Healthcare

Zhongsheng Quanpei is a platform company focused on peptide lead drug discovery, specializing in the construction of ultra-large-capacity peptide libraries and peptide new drug screening and R&D services, committed to building a new global engine for peptide drug development.

Latest round: Series B (2022)